Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis
Abstract Background Fibronectin type III domain containing 3B (FNDC3B), a member of the fibronectin type III domain-containing protein family, has been indicated in various malignancies. However, the precise role of FNDC3B in the progression of pancreatic cancer (PC) still remains to be elucidated....
Main Authors: | Yizhi Wang, Yang Kong, Qifan Yang, Cheng Zhong, Dongkai Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-04-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-024-01823-6 |
Similar Items
-
Rs420137, rs386360 and rs7763726 polymorphisms in fibronectin type III domain containing 1 are associated with susceptibility to coronary heart disease: Analysis in the Han population
by: Xiaodan He, et al.
Published: (2022-10-01) -
GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
by: Bo Liu, et al.
Published: (2021-05-01) -
Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma
by: Guanxiang Zhuo, et al.
Published: (2025-01-01) -
Identification of prognostic immune-related lncRNAs in pancreatic cancer
by: Yan Ma, et al.
Published: (2022-11-01) -
Comparative Genomic Characterization of Buffalo Fibronectin Type III Domain Proteins: Exploring the Novel Role of FNDC5/Irisin as a Ligand of Gonadal Receptors
by: Siwen Wu, et al.
Published: (2021-11-01)